• Ziphius Vaccines and University of Antwerp announce collaboration agreement for optimized delivery of saRNA-based vaccines & therapeutics

    Thursday June 9th 2022

  • Dolmen Engineering joins international consultancy company NIRAS

    Thursday June 9th 2022

  • Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software

    Tuesday May 31st 2022

  • Precirix strengthens patent portfolio of its precision radiopharmaceuticals platform

    Tuesday May 31st 2022

  • VUB and VIB construct a bio-incubator in the former Willy Van Der Meeren buildings

    Tuesday May 31st 2022

  • GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc.

    Tuesday May 31st 2022

  • argenx announces the UK MHRA has granted early access to efgartigimod for generalized myasthenia gravis

    Tuesday May 31st 2022

  • CureVac partners with myNEO to identify novel antigen targets for mRNA-based cancer vaccine development

    Wednesday May 25th 2022

  • Your news here?

  • Biotalys’ first biocontrol Evoca wins World BioProtection Award 2022 for Best Biofungicide Product

    Wednesday May 25th 2022

  • Latest field trials validate strength of Biotalys’ first biocontrol Evoca

    Thursday May 19th 2022

  • Belgian biotech in European Top-3 despite turbulent times

    Wednesday May 18th 2022


Strategic Partners